GlassScriptPhysician profile
Stephen C Tidwell
NPI 1326149683
$2,703.63
in general payments reported to CMS, 2019-2025
36 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2020: $112 · 2021: $117 · 2022: $304 · 2023: $558 · 2024: $754 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,686.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $383.66 | 2019-2025 | Altis |
| Abbvie INC. | $316.68 | 2019-2025 | Liletta |
| Mayne Pharma Commercial LLC | $295.27 | 2021-2024 | |
| Caldera Medical, INC | $183.03 | 2023-2024 | Desara |
| Exeltis, USA INC. | $142.75 | 2023-2025 | Slynd |
| Novo Nordisk INC | $109.31 | 2024-2025 | Wegovy |
| Medtronic, INC. | $99.75 | 2022-2024 | Interstim |
| Bausch Health US, LLC | $96.95 | 2021-2023 | Wellbutrin, Aplenzin |
| Organon LLC | $89.77 | 2024-2025 | Nexplanon |
| Astellas Pharma US INC | $88.05 | 2019-2024 | Veozah, Myrbetriq |
| Boston Scientific Corporation | $87.71 | 2019-2025 | General - Female Sui, Solyx Sis System |
| Bayer Healthcare Pharmaceuticals INC. | $84.97 | 2019-2025 | |
| Shield Therapeutics INC | $73.03 | 2023-2025 | Accrufer |
| Daiichi Sankyo INC. | $63.93 | 2019-2020 | |
| Intuitive Surgical, INC. | $53.81 | 2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $53.46 | 2023 | |
| Therapeuticsmd, INC. | $49.53 | 2019-2020 | |
| Allergan, INC. | $43.57 | 2019 | |
| Medline Industries LP | $40.29 | 2023 | |
| Lilly USA, LLC | $38.25 | 2024-2025 | Zepbound |
| Pfizer INC. | $33.81 | 2020-2024 | |
| Idorsia Pharmaceuticals US INC | $32.47 | 2023 | Quviviq |
| Ethicon US, LLC | $31.46 | 2024 | Ethicon, Evicel Fibrin Sealant (Human), Vistaseal |
| Biogen, INC. | $28.93 | 2025 | Zurzuvae |
| Baxter Healthcare | $23.83 | 2024 | Seprafilm |
| Axsome Therapeutics, INC. | $23.27 | 2025 | Auvelity |
| Corium, LLC | $18.29 | 2024 | Azstarys |
| Organogenesis INC. | $16.51 | 2024 | |
| Amgen INC. | $16.33 | 2024 | Prolia, Evenity |
| Avion Pharmaceuticals | $13.20 | 2022 | |
| Covidien LP | $13.17 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.96 | 2019 | |
| Dysis Medical, INC. | $12.85 | 2022 | |
| Minerva Surgical, INC | $12.10 | 2022 | |
| Amag Pharmaceuticals, INC. | $11.16 | 2019 | |
| Aspira Women'S Health INC | $9.52 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Tidwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.